Skip to content

COMPARISON OF MEAN DURATION OF POST OPERATIVE ANALGESIA FOLLOWING ADDITION OF DEXMEDETOMIDINE TO ROPIVACAINE VERSUS PLAIN ROPIVACAINE ON ULTRASOUND GUIDED RECTUS SHEATH BLOCK

COMPARISON OF MEAN DURATION OF POST OPERATIVE ANALGESIA FOLLOWING ADDITION OF DEXMEDETOMIDINE TO ROPIVACAINE VERSUS PLAIN ROPIVACAINE ON ULTRASOUND GUIDED RECTUS SHEATH BLOCK IN PATIENTS UNDERGOING MIDLINE LAPAROTOMIES

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07254130
Enrollment
209
Registered
2025-11-28
Start date
2025-02-28
Completion date
2025-09-20
Last updated
2025-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Midline Laparotomy

Brief summary

To compare the mean duration of postoperative analgesia following addition of dexmedetomidine to ropivacaine versus plain ropivacaine in ultrasound guided rectus sheath block in patients undergoing midline laparotomies

Interventions

PROCEDURERectus Sheath Block

In Dexmedetomedine combined with ropivacaine group, under ultrasound guidance, the needle will be advanced posterior to the rectus muscle, and 20 ml of 0.25% ropivacaine mixed with 1ug/kg body weight will be injected to hydrodissect the rectus muscle from the posterior sheath. In ropivacine only group, under ultrasound guidance, the needle will be advanced posterior to the rectus muscle, and 20 ml of 0.25% ropivacaine will be injected to hydrodissect the rectus muscle from the posterior sheath.

Sponsors

Quaid-e-Azam Medical College
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Patients with age 30 - 60 years. * Patients that will be scheduled for laparotomy under general anesthesia. * ASA (American Society of Anesthesiologist) s

Exclusion criteria

* Patient who will refuse for participation in study. * Infection at site of Rectus Sheath block. * History of any addiction. * Sensitivity to the local anesthetics. * Patient with pre-existing coagulation abnormalities INR more than 1.5.

Design outcomes

Primary

MeasureTime frameDescription
Mean duration of analgesiaBaseline , 30 minutes , 2 hours, 4 hours , 6 hours , 8 hours , 12 hours , 24 hoursAssessed using the visual analogue score(VAS) ranging from 0-10 (0=no pain , 10= most severe unbearable pain)

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026